The impact of adjuvant endocrine therapy (AET) omission in ER-low (1-10%) early-stage breast cancer.
Some results have been hidden because they may be inaccessible to you
Show inaccessible resultsSome results have been hidden because they may be inaccessible to you
Show inaccessible results